Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05688007
Other study ID # MS 168/2021
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 1, 2021
Est. completion date December 30, 2022

Study information

Verified date January 2023
Source Ain Shams Maternity Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This observational study aims to test the level of parathyroid hormone in pregnant women. The main question it aims to answer is: n Pregnant women, are the levels of serum PTH, calcium, magnesium, phosphorus & albumin similar in both preterm and term births?


Description:

- Approval from ethical committee will be sought. - Patients will be enrolled from Ain Shams University Maternity Hospital labor ward and antenatal outpatient clinic. - History, examination and fetal ultrasound will be done to identify eligible patients. History: a full detailed history including personal, menstrual, obstetric, present, past history and family history will be obtained. Accurate last menstrual period date will be obtained, and gestational age will be calculated using Naegele's rule or first trimester ultrasound to identify preterm patients with gestational age (28-36 weeks). Examination: general, abdominal and vaginal examination to identify patients in established labor with Regular uterine contractions are at least 3 in 10 min each lasting 40 seconds. Progressive cervical dilatation (at least 4 cm). Ultrasound: for (viability of fetus, fetal biometry and estimated fetal weight, amniotic fluid, placental localization). Thus, two groups of patients will be identified: 1. Cases: established preterm labor - gestational age: (28-36 weeks) 2. Controls: pregnant women not in labor - gestational age: (28- 36 weeks) - Venous blood samples will be withdrawn about (3ml) once from every patient within one hour from inclusion into the study to measure serum parathyroid hormone, calcium, magnesium, phosphorus and albumin levels. - Samples will not be collected from an arm with an intravenous catheter if alternate sites are available. - Patient collection site will be appropriately disinfected prior to sample collection. - After collection, samples will be put in a red or yellow tube (serum separating tube) with a serum gel separator. - Samples will be gently mixed immediately following collection into tube to ensure proper preservation of the analytes. 180° tube inversion, allowing bubble to travel the length of the tube, followed by return to upright position is one mix. - Samples will be delivered to laboratory within 30 to 60 minutes. - Data will be collected and recorded in a case report form (Age, parity, previous preterm births/ miscarriage, gestational age, measured levels of serum PTH, calcium, magnesium, phosphorus & albumin , mode of delivery, birth weight). - Statistical analysis will be done to get results.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date December 30, 2022
Est. primary completion date October 16, 2022
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - Pregnant women aged (18-40). - Gestational age (28-36 weeks). Exclusion Criteria: - Known maternal disease as diabetes, hypertension, renal disease, cardiac disease and liver disease. - Known hypo or hyperparathyroidism - Multiple pregnancy - Polyhydramnios - Premature rupture of membrane - Antepartum Hemorrhage - Uterine malformations e.g. bicornuate uterus - Smoking

Study Design


Intervention

Diagnostic Test:
parathyroid hormone level
Serum level of parathyroid hormone
serum electrolytes
Serum levels of: magnesium, phosphorus, calcium, and albumin

Locations

Country Name City State
Egypt Ain Shams Maternity Hospital Cairo

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams Maternity Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary parathyroid hormone serum level of parathyroid hormone (ng/L) 1 day
Secondary Calcium serum calcium level (mg/dl) 1 day
Secondary Magnesium serum magnesium level (meq/L) 1 day
Secondary Phosphorus serum phosphorus level (mg/dl) 1 day
Secondary Albumin serum albumin level (g/dl) 1 day
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06168149 - The Relationship of Fetal Lung Elastography Values With the Development of Respiratory Distress in Cases of Preterm Labor
Completed NCT02538718 - Efficacy and Safety of MgSO4 as Tocolytics Compared to Ritodrine in Preterm Labor N/A
Not yet recruiting NCT05864066 - Cyclin-dependent Kinase Inhibitor 2A (Placental Senescence Marker) on Labor-related Signals
Terminated NCT03715530 - Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women N/A
Recruiting NCT03638037 - Correlation Between Maternal Vitamin D Level And Preterm Birth
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT02536352 - Effect of Supplementation of Fluoride on Maternal Periodontal Health, Preterm Delivery, and Perinatal Well-Being Early Phase 1
Withdrawn NCT03122704 - Group B Streptococcus (GBS) Infection and in Preterm Labor Women Conceived Through IVF N/A
Recruiting NCT01518816 - Role of Serum Total Antioxidant Level in Preterm Labor N/A
Recruiting NCT04590677 - Prediction of the Onset of Term and Preterm Labour
Completed NCT03112018 - Strengthening Facility-based Intrapartum/Immediate Newborn Care to Reduce Mortality of Preterm Infants in Migori County, Kenya and Busoga Region, Uganda N/A
Active, not recruiting NCT04301518 - Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs N/A
Completed NCT03785795 - Multichannel EMG Diagnosing True Preterm Labor
Withdrawn NCT02351310 - Effectiveness of ACS in Extreme Preemies Phase 3
Not yet recruiting NCT01985594 - Utrogestan Versus Nifedipine as Tocolysis for Preterm Labor: a Randomised Controlled Trial Phase 2
Not yet recruiting NCT04532086 - Uterocervical Angle and Preterm Labour
Completed NCT04605172 - Lockdown Impact on Spontaneous Premature Birth in a Level III NICU
Recruiting NCT04417595 - Investigating N-3 Fatty Acids to Prevent Neonatal Tobacco-related outcomeS Phase 2
Completed NCT03923023 - Impact of the PREEMI Package on Neonatal Mortality
Recruiting NCT06157203 - Labor Status Monitor for Diagnosing True vs False Labor in Preterm Patients